Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             23 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgement of reviewers 2016 2017
81 2 p. 425
artikel
2 A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study) Kagawa, Shunsuke
2017
81 2 p. 387-392
artikel
3 A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting Tanaka, Ichidai
2017
81 2 p. 339-345
artikel
4 A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis Hanke, Nina
2017
81 2 p. 291-304
artikel
5 A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia Kim, Sung-Yong
2018
81 2 p. 393-398
artikel
6 B7-H3 in tumors: friend or foe for tumor immunity? Li, Gen
2018
81 2 p. 245-253
artikel
7 Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study Kataoka, Yuki
2017
81 2 p. 333-337
artikel
8 Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men Markus, Richard
2017
81 2 p. 419
artikel
9 Correction to: Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study Jong, Jan de
2017
81 2 p. 423
artikel
10 Correction to: Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC) Chen, Shang-Chiung
2017
81 2 p. 421-422
artikel
11 CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine Zhou, Xinna
2017
81 2 p. 365-372
artikel
12 Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells Fedorchuk, Olexandr
2017
81 2 p. 373-385
artikel
13 Influence of the ABCB1 polymorphisms on the response to Taxane-containing chemotherapy: a systematic review and meta-analysis Jiang, Qi
2017
81 2 p. 315-323
artikel
14 Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine Phua, Lee Cheng
2017
81 2 p. 277-289
artikel
15 Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma Mistry, Hitesh B.
2017
81 2 p. 325-332
artikel
16 Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients Schoch, L. K.
2017
81 2 p. 347-354
artikel
17 Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia Völler, Swantje
2017
81 2 p. 305-314
artikel
18 Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors Chan, Emily
2017
81 2 p. 355-364
artikel
19 Positioning of proteasome inhibitors in therapy of solid malignancies Roeten, Margot S. F.
2017
81 2 p. 227-243
artikel
20 Prediction of neutrophil reduction using plasma paclitaxel concentration after administration in patients with uterine, ovarian, or cervical cancers in an outpatient clinic Ishikawa, Motoaki
2018
81 2 p. 399-411
artikel
21 Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study Shien, Tadahiko
2017
81 2 p. 269-275
artikel
22 Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations Liu, Xiaojun
2017
81 2 p. 255-267
artikel
23 The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer Williams, Grant R.
2017
81 2 p. 413-417
artikel
                             23 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland